Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

NCT03059329 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT03059329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03059329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
Lead sponsor
Eisai Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
August 1, 2016
Completion date
September 13, 2019
Enrollment
3,809 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

partial seizures (with or without secondary generalized seizures), primary generalized tonic-clonic seizures